Anti-Shroom2 autoantibody for detecting autoimmune system diseases as well as product and application thereof

An autoantibody, autoimmune technology, applied in the biological field, can solve the problems that have not yet been reported on Shroom2 autoantibodies

Pending Publication Date: 2022-07-12
SHAANXI MYBIOTECH CO LTD
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there is no report on the use of Shroom2 autoantibodies in the detection of autoimmune diseases of the nervous system

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-Shroom2 autoantibody for detecting autoimmune system diseases as well as product and application thereof
  • Anti-Shroom2 autoantibody for detecting autoimmune system diseases as well as product and application thereof
  • Anti-Shroom2 autoantibody for detecting autoimmune system diseases as well as product and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0050] Example 1: Immunofluorescence of rat primary neuronal cells

[0051] Step 1 Rat primary neuronal cell isolation

[0052] 1. Pregnant mice were anesthetized with 10% chloral hydrate, soaked in 75% alcohol for 3 minutes, and the fetal mice were taken out from the biological safety cabinet;

[0053] 2. Use pre-chilled HBSS (137mM NaCl, 5.4mM KCl, 0.6mM MgSO 4 ·7H 2 O, 0.5mM MgCl 2 ·6H 2 O, 0.3mM Na 2 HPO 4 ·2H 2 O, 0.4mM kH 2 PO 4, 5.6mM Grucose, 4.2mM NaHCO 3 , pH7.2~7.4) wash the fetal mouse twice, dissect out the fetal brain in pre-cooled HBSS and soak it in pre-cooled DMEM;

[0054] 3. Discard DMEM and cut the tissue block into 1m with ophthalmic scissors 3 size mixture. Papain was added (at a concentration of 2 mg / ml). Digest at 37°C for 30 minutes in a 10cm dish with gentle shaking every 5 minutes. Generally 20ml of digestive juice for 10 to 15 brain tissues;

[0055] 4. After digestion, transfer the cells to a 50ml centrifuge tube, add 20ml DMEM to re...

Embodiment 2

[0082] Example 2: Immunoprecipitation of shroom2

[0083] 1. Take 6 dishes of rat primary neuron cells, discard the supernatant, wash twice with PBS, fix with 0.4% paraformaldehyde for 10 min, and wash three times with 1× HEPES;

[0084] 2. Serum incubation: Take 10ul of patient 1 serum and add it to 10ml of DMEM (1:1000 dilution), filter it with a 0.22um filter, add it to the fixed cells, and incubate at room temperature for 2h;

[0085] 3. Add 15ul beads to a 2mL tube, wash 3 times with equilibration solution, and seal with 300ul 4% BSA for 2h;

[0086] 4. Put the incubated cells on ice, discard the supernatant, wash twice with PBS, add 500ul lysis buffer (150mM NaCl, 1mM EDTA, 100mM Tris-HCl, 0.5% sodium deoxycholate, 1% TritonX-100, 0.1% SDS, pH 7.5), collect cells, add protease inhibitor with a final concentration of 1×, lyse for 30 min, shake at intervals, centrifuge at 15,000 rpm for 30 min, take the supernatant, and measure the concentration;

[0087] 5. Add the supe...

Embodiment 3

[0093] Example 3: Immunoblotting

[0094] 1. Electrophoresis: take the sample obtained in step 7 of Example 2 for SDS-PAGE;

[0095] 2. Transfer membrane: after electrophoresis is completed, use wet method to transfer membrane, and the transfer condition is 200mA, 90min;

[0096] 3. Blocking: Block with 5% skimmed milk powder at room temperature for 1 hour;

[0097] 4. Primary antibody incubation: incubate anti-shroom2 polyclonal antibody (antibody purchased from sigma) at a ratio of 1:2000, and incubate at room temperature for 2 hours;

[0098] 5. Washing: TBST wash 3 times, 5min each time;

[0099] 6. Secondary antibody incubation: add HRP-labeled secondary antibody and incubate at room temperature for 1h

[0100] 7. Washing: TBST wash 3 times, 5min each time;

[0101] 8. Color development: add chemiluminescent solution and record the results.

[0102] Experimental results:

[0103] Western blot analysis of immunoprecipitates received with patient 1 serum, but not with...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an anti-Shroom2 autoantibody for detecting autoimmune system diseases as well as a product and application of the anti-Shroom2 autoantibody. The kit prepared by the invention can realize detection of the Shroom2 autoantibody, and can be used for diagnosing nervous system diseases, especially nervous system diseases related to one or more symptoms; the symptoms include cerebellar degeneration, mental behavior disorder, cognitive impairment, visual impairment, memory deterioration, speech disorder, dyskinesia, level of consciousness decline, autonomic nerve dysfunction or hearing disorder. The kit prepared by the application can also be used for distinguishing autoimmune diseases, especially autoimmune diseases and non-autoimmune diseases of a nervous system.

Description

technical field [0001] The invention belongs to the field of biotechnology, and in particular relates to an autoimmune system disease marker anti-Shroom2 autoantibody and its product and application. Background technique [0002] Nervous system autoimmune diseases are autoimmune diseases in which autoimmune cells, immune molecules, etc. attack the nervous system as the main pathogenic mechanism. Such diseases can occur in the central nervous system, peripheral nervous system and nerve-muscle junction. Common autoimmune diseases of the nervous system include: autoimmune encephalitis, central nervous system demyelinating disease, stiff person syndrome, immune-mediated peripheral neuropathy, autoimmune cerebellar ataxia, myasthenic syndrome, etc. In the immune response, pathogenic antibodies acting on autoantigens of the nervous system are collectively referred to as autoantibodies of the nervous system. With the development of science, the spectrum of autoimmune diseases of t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07K16/18C07K14/47C07K19/00C12N15/12C12N15/62G01N33/68G01N33/543
CPCC07K16/18C07K14/4702G01N33/6896G01N33/6893G01N33/543G01N33/68C07K2317/00C07K2319/00G01N2800/28G01N2800/2835G01N2800/2814
Inventor 闫亚平任妮柴单单曹玉妍程静美封雪李科
Owner SHAANXI MYBIOTECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap